|4Feb 6, 4:10 PM ET

Aggarwal Sanjeev 4

4 · EVERSPIN TECHNOLOGIES INC. · Filed Feb 6, 2026

Research Summary

AI-generated summary of this filing

Updated

Everspin (MRAM) CEO Sanjeev Aggarwal Exercises Options

What Happened
Sanjeev Aggarwal, President, CEO and a director of Everspin Technologies (MRAM), exercised stock option derivatives on February 4, 2026 to acquire a total of 7,084 common shares. The exercises consisted of 834 shares at $9.12 (cost $7,606) and 6,250 shares at $6.35 (cost $39,688), for a combined cash outlay of roughly $47,294. The filing also shows the corresponding derivative option interests were converted/terminated (reported as disposals at $0).

Key Details

  • Transaction date: 2026-02-04; Form 4 filed 2026-02-06 (timely within the usual 2-business-day window).
  • Exercise details: 834 shares @ $9.12 = $7,606; 6,250 shares @ $6.35 = $39,688; total acquired = 7,084 shares for ~$47,294.
  • Dispositions at $0 reflect conversion/cancellation of the derivative (the options) upon exercise.
  • Footnote: Fully vested (F1).
  • Shares owned after the transaction: Not specified in the provided filing excerpt.

Context

  • Transaction code M indicates option exercise. No shares were reported sold in this filing; the insider paid exercise prices to convert options into stock (not a cashless sale).
  • Exercises are commonly routine for executives to realize vested equity; they represent acquisition of shares rather than a sell signal.

Insider Transaction Report

Form 4
Period: 2026-02-04
Aggarwal Sanjeev
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2026-02-04$9.12/sh+834$7,606550,246 total
  • Exercise/Conversion

    Common Stock

    2026-02-04$6.35/sh+6,250$39,688556,496 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F1]
    2026-02-048340 total
    Exercise: $9.12Exp: 2028-03-12Common Stock (834 underlying)
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F1]
    2026-02-046,2500 total
    Exercise: $6.35Exp: 2029-02-10Common Stock (6,250 underlying)
Footnotes (1)
  • [F1]Fully vested.
Signature
/s/ Cesare Suardi, Attorney-in-Fact for Sanjeev Aggarwal|2026-02-06

Documents

1 file
  • 4
    wk-form4_1770412208.xmlPrimary

    FORM 4